In this way, an MRI-based radiomics signature has the potential to preoperatively predict the expression of CD8A, thereby contributing to the preoperative prediction of prognosis and immunotherapeutic susceptibility in bladder cancer. The gene discussed is CD8A; the disease is urinary bladder carcinoma.